Description

Pooch ATOVA Oral Suspension

Atovaquone Oral Suspension

Atovaquone USP 750 mg per 5 ml | For Dogs & Cats

Manufactured/Marketed by:
Panav Bio-Tech Pvt. Ltd.

Country of Origin: India

Dosage form: Oral suspension

Presentation:

30 ml / 50 ml Oral Suspension

Ingredients & Composition:

Ingredient                    Amount / Strength
Atovaquone USP        750 mg per 5 ml
Aqueous Base             q.s.
Colour: Quinoline Yellow

Description / Action:

Pooch ATOVA Oral Suspension contains Atovaquone 750 mg/5 ml for treatment of Babesia gibsoni in dogs and cats, offering precise liquid dosing and combination therapy with azithromycin.

Key Highlights:

India’s First Atovaquone Suspension
Pioneering liquid formulation introduced to Indian veterinary market for the first time.

Precise Liquid Dosing
Oral suspension allows accurate dose titration for dogs & cats of any size and B.W.

750 mg per 5 ml Concentration
High-concentration suspension minimises volume while maintaining therapeutic dose.

Anti-Babesia gibsoni
Same trusted antiprotozoal action as tablets in a convenient liquid form.

Combination Protocol Ready
Easily combined with azithromycin for the recommended Babesia gibsoni protocol.

Supports improved survival
In feline cytauxzoonosis when used in combination therapy.

Class:

Antiprotozoal/ Antimicrobial
Hydroxynaphthoquinone derivative

Indication / Uses:

Babesia gibsoni Infection: Tick-borne protozoal infection — liquid form ideal for dogs & cats that cannot swallow tablets.

Small Dogs and Puppies with Babesiosis: Precise liquid dosing especially valuable in very small or juvenile dogs.

Additional documented veterinary uses (literature):

• Used in combination with azithromycin for treatment of Babesia gibsoni infection in dogs.
• Used as part of combination therapy for Cytauxzoon felis infection in cats where clinically indicated.
• May be considered for selected protozoal infections according to current veterinary recommendations.

Dosage and administration:

Administer with food, particularly a fatty meal where possible, to improve atovaquone absorption.

Pharmacology:

Atovaquone selectively inhibits mitochondrial electron transport in susceptible protozoa by blocking the cytochrome bc1 complex, leading to collapse of mitochondrial membrane potential and inhibition of nucleic acid and ATP synthesis.

Overdoses / Side effects / Contraindications / Warnings:

Generally well tolerated at recommended doses. Mild vomiting, diarrhoea, reduced appetite or lethargy may occur.

Administer with food to maximize oral absorption. Use cautiously in animals with severe hepatic dysfunction. Hypersensitivity to atovaquone is a contraindication.

Combination therapy with azithromycin is recommended for Babesia gibsoni to improve treatment success and reduce relapse.

Pharmaceutical precautions / Instructions:

Shake well before use. Store below 25°C in a dry place.

Protect from direct sunlight. Keep bottle tightly closed after use.

Keep out of reach of children. For veterinary use only.

Safety: Age / Pregnancy / Withdrawal:

Age: Suitable for dogs and cats under veterinary supervision.

Pregnancy/Lactation: Safety has not been fully established; use only after veterinary risk-benefit assessment.

Withdrawal: Not applicable for companion animals.

Drug Interactions:

Commonly administered with Azithromycin for canine Babesia gibsoni infection.

Concomitant administration with drugs affecting gastrointestinal absorption may alter bioavailability.

No major clinically significant veterinary drug interactions have been widely reported when used appropriately.

Substitute: Pooch Atova Tablets, Vaquon Tablets, ATAVON Tablet, VETDOX-AQ Tablets & Syrup,